Jason Maynard named CEO at Qualtrics; Jenny Lay-Flurrie gets a new gig at Microsoft; and more key personnel changes.

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse ...

Oracle (ORCL) is burning cash for AI, while still paying out $1.4B in dividends. Larry Ellison holds 40% ORCL stock. 2 more ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Oracle's strong AI growth fuels investor interest in its booming cloud computing sector. Anyone can buy Oracle shares through a brokerage using specific order details. Oracle aims for double-digit ...

Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Executives from Recursion (Nasdaq: RXRX), a leading clinical stage TechBio ...

Welcome back! The dollar is down and gold is up, prompting chatter about a “sell America” trade. At Breakingviews, we don’t see much evidence of it. Let us know what we’re missing. Was this newsletter ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...